I totally agree with you LeMetier.If Pfizer took control of RAP,...

First 10 Last

Share
Profile

Follow
JoCool

145 Posts.

116

13/04/22

09:30

Post #: 60822591
Share
Originally posted by LeMetier: ↑

At face value the BOD wants to sell Resapp @11.5c / share and in the process throw all the holders who bought in above that price, which is probably the majority, under the bus. And at the same time deny shareholders the growth in stock value that initially motivated their purchase.

But it could in fact be the case that the BOD after extensive consultation and lengthy consideration, unequivocally expect shareholders to vote NO!

If it is in fact the later then it is a low risk, potentially high reward strategy.

From which Resapp and its shareholders can expect:

research & development licence between Resapp and Pfizer
$3M cash
international recognition and validation for Resapp courtesy of Pfizer
an open door to FDA regulatory approval, amongst others
worldwide acceptance and usage of Resapp diagnostic tools not just for covid but also pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease; as well as those still to be developed

The list goes on and on. And I expect enormous potential for my holdings to grow significantly over the coming years if Resapp builds a close relationship with Pfizer; or a company of similar standing.

From the outside we cannot know for sure if this is a clever strategic move by the BOD, but it very well may be. Plus it is a worthwhile thought experiment.

What is the BOD motive?

Expand

I totally agree with you LeMetier.
If Pfizer took control of RAP, there would be no need to have the research and development clause at all in the bid. The
BOD must have insisted and also insisted on the $3M cash up front.

Just my opinion,
RAP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

KOB

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

MGU

New results confirm Buena Vista's iron grades potential

MRC

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

1CG

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

There are more pages in this discussion • 88 more messages in this thread...

First 10 Last

Add RAP (ASX) to my watchlist

(20min delay)
Last 20.5¢		Change 0.000(0.00%)		Mkt cap ! $176.2M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

I totally agree with you LeMetier.If Pfizer took control of RAP,...

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

New results confirm Buena Vista's iron grades potential

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

Featured News

Featured News

I totally agree with you LeMetier.If Pfizer took control of RAP,...

Top Stories

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

New results confirm Buena Vista's iron grades potential

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

Featured News

Featured News